Aduhelm (aducanumab) - Neurimmune, Eisai
ondansetron ultra-low dose (AD04) - Adial
Leqembi (lecanemab-irmb) - Biogen, Eisai
alhydrogel injectable (AD04) - ADvantage Therap
Kisunla (donanemab-azbt) - Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/40953123
 
Achim Schneeberger; Agustin Fernández Santana; Benjamin Haaland; Bruno Dubois; Craig Mallinckrodt; Joshua Christensen; Oliver Peters; Rudolph E Tanzi; Samuel P Dickson; Suzanne B Hendrix; Timo Grimmer
 
Sep 16, 2025
 
Next